Efficacy and safety of first line oral therapies in relapsing-remitting multiple sclerosis: Dimethyl fumarate vs teriflunomide in the Chieti experience

被引：0
|
作者：
Di Tommaso, V. [1 ]
Mancinelli, L. [2 ]
di Ioia, M. [2 ]
Farina, D. [2 ]
Travaglini, D. [2 ]
Pietrolongo, E. [2 ]
De Luca, G. [2 ]
Lugaresi, A. [3 ]
机构：
[1] MS Ctr, Chieti, Italy
[2] G DAnnunzio, Chieti, Italy
[3] Univ Bologna, Alma Mater Studiorum, Bologna, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1648
引用
收藏
页码：870 / 871
页数：2
相关论文
共 50 条
  • [31] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    [J]. JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
  • [32] Successful treatment with dimethyl fumarate in a child with relapsing-remitting multiple sclerosis
    Saijo, Naoya
    Abe, Yu
    Oikawa, Yoshitsugu
    Okubo, Yukimune
    Endo, Wakaba
    Numata-Uematsu, Yurika
    Takahashi, Toshiyuki
    Uematsu, Mitsugu
    [J]. BRAIN & DEVELOPMENT, 2022, 44 (05): : 353 - 356
  • [33] Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    de Sa, Joao
    Ferreira, Joao
    Macedo, Ana M.
    [J]. REVISTA DE NEUROLOGIA, 2023, 76 : S1 - S6
  • [34] The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review
    Shahtaheri, Rahil Sadat
    Nikfar, Shekoufeh
    Khorasani, Elahe
    Sabbagh-Baniazad, Mansoureh
    Goudarzi, Zahra
    Emamikhah, Maziar
    [J]. CURRENT JOURNAL OF NEUROLOGY, 2020, 19 (03): : 138 - 145
  • [35] Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
    Karl E. Carlström
    Ewoud Ewing
    Mathias Granqvist
    Alexandra Gyllenberg
    Shahin Aeinehband
    Sara Lind Enoksson
    Antonio Checa
    Tejaswi V. S. Badam
    Jesse Huang
    David Gomez-Cabrero
    Mika Gustafsson
    Faiez Al Nimer
    Craig E. Wheelock
    Ingrid Kockum
    Tomas Olsson
    Maja Jagodic
    Fredrik Piehl
    [J]. Nature Communications, 10
  • [36] Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes
    Carlstrom, Karl E.
    Ewing, Ewoud
    Granqvist, Mathias
    Gyllenberg, Alexandra
    Aeinehband, Shahin
    Enoksson, Sara Lind
    Checa, Antonio
    Badam, Tejaswi V. S.
    Huang, Jesse
    Gomez-Cabrero, David
    Gustafsson, Mika
    Al Nimer, Faiez
    Wheelock, Craig E.
    Kockum, Ingrid
    Olsson, Tomas
    Jagodic, Maja
    Piehl, Fredrik
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [37] Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis
    Chan, Andrew
    de Seze, Jerome
    Comabella, Manuel
    [J]. CNS DRUGS, 2016, 30 (01) : 41 - 51
  • [38] Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS)
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Zhang, Annie
    Meltzer, Leslie
    Kurukulasuriya, Nuwan C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 57 - 66
  • [39] Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study
    Hutchinson, M.
    Fox, R. J.
    Phillips, J. T.
    Miller, D. H.
    Havrdova, E.
    Kita, M.
    Yang, M.
    Zhang, R.
    Novas, M.
    Sweetser, M. T.
    Viglietta, V.
    Dawson, K. T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (05) : 683 - 683
  • [40] COST-UTILITY ANALYSIS OF DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA
    Ordonez, J.
    Serafini, P.
    Machado, M.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A434 - A434
12345